Market Tracker

06/23 5:16pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

16.70
Delayed Data
As of Jun 23
 +0.20 / +1.21%
Today’s Change
7.75
Today|||52-Week Range
32.20
+26.04%
Year-to-Date

Today’s Trading

Previous close16.50
Today’s open16.45
Day’s range16.10 - 16.85
Volume4,468,183
Average volume (3 months)2,229,948
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-1,327.78%
Earnings growth (this year)-44.12%
Earnings growth (next 5 years)+9.80%
Revenue growth (last year)-4.19%
P/E ratioNM
Price/Sales1.14
Price/Book1.97

Competitors

 Today’s
change
Today’s
% change
EGRXEagle Pharmaceutical...+0.66+0.81%
TXMDTherapeuticsMD Inc-0.02-0.35%
GBTGlobal Blood Therape...+0.60+2.05%
DERMDermira Inc+0.80+2.60%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)$0.14
Annual revenue (last year)$824.4M
Annual profit (last year)-$472.0M
Net profit margin-57.26%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Paul M. Bisaro
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts